Contamination of drugs with nitrosamines: health risks and drug recalls in Brazil

Authors

  • Juliana Yi Dan Wu Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz. Avenida Doutor Arnaldo, 355. CEP 01246-000. São Paulo, SP, Brasil.
  • Jaqueline Kalleian Eserian Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz. Avenida Doutor Arnaldo, 355. CEP 01246-000. São Paulo, SP, Brasil.
  • Márcia Lombardo Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz. Avenida Doutor Arnaldo, 355. CEP 01246-000. São Paulo, SP, Brasil.

DOI:

https://doi.org/10.14450/2318-9312.v34.e3.a2022.pp260-265

Keywords:

health surveillance, drug recalls, nitrosamines

Abstract

Nitrosamines are mutagenic compounds with high carcinogenic potential included in the cohort-of-concern list. In 2018, nitrosamine impurities were detected in active pharmaceutical ingredients and pharmaceuticals. Since then, controlling and monitoring nitrosamines in drugs has become a priority for regulatory agencies worldwide to protect the population’s health. This work aimed to survey drug recalls in Brazil from 2018 to March 2022 due to suspicion or confi rmation of the presence of nitrosamines. For this, online searches were carried out on the Brazilian Health Surveillance Agency website. The surveillance actions resulted in the suspension of imported active pharmaceutical ingredients and the recall of several batches of drugs
marketed in Brazil, such as valsartan, losartan, ranitidine, metformin, and varenicline. Drug recalls involved 20 companies and revealed many products, especially those containing ranitidine and metformin. Although nitrosamine impurities in drugs are found in low concentrations, products of continuous use and/or high doses deserve special attention to guarantee the treatment’s safety. 

Author Biography

Márcia Lombardo, Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz. Avenida Doutor Arnaldo, 355. CEP 01246-000. São Paulo, SP, Brasil.

Doutora em Ciências pela FCF/USP

Pesquisadora do Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz

http://lattes.cnpq.br/1230585657136402

Downloads

Published

2022-09-30

How to Cite

Wu, J. Y. D., Eserian, J. K., & Lombardo, M. (2022). Contamination of drugs with nitrosamines: health risks and drug recalls in Brazil. Infarma - Pharmaceutical Sciences, 34(3), 260–265. https://doi.org/10.14450/2318-9312.v34.e3.a2022.pp260-265

Issue

Vol. 34 No. 3 (2022)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).